A Phase IIIb Study of Intermittent Versus Continuous Hormone Deprivation Treatment With ELIGARD

Clinical trial NCT00378690 · COMPLETED

Trial details

NCT number: NCT00378690
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2006-03-01
Primary completion: 2011-06-01
Enrollment: 706

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.